Patent ID: 6627646
Filing Date: 2003-09-30
Classification: A61P,C07D

Abstract:
Norastemizole in the form of a crystalline solid comprising at least 95% of a first polymorph having peaks at the diffraction degrees with the intensity shown below in an X-ray powder diffraction pattern:No.2&thgr;d19.03296.78217210.248.63159310.5888.34866411.72737.54003512.54177.05218613.386.61217713.62846.4922814.58466.06864915.83585.591851017.265.133521118.14.897131219.324.590551319.624.521031420.124.409791520.50054.32881620.99464.228021721.224.183621821.83514.067141922.08874.021012022.94273.873232123.563.773132224.73.60152325.44193.498142426.983.30212527.53.240832627.983.1863227293.076522829.463.029522929.82.995733030.662.913633131.02382.880293231.9912.795383332.82.72826.!